N
CGON icon

Nuveen’s CG Oncology CGON Stock Holding History

Nuveen’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.69M Sell
128,414
-6,278
-5% -$356K ﹤0.01% 1632
2025
Q4 		$5.59M Sell
134,692
-2,286
-2% -$94.6K ﹤0.01% 1860
2025
Q3 		$5.52M Sell
136,978
-1,804
-1% -$52.4K ﹤0.01% 1859
2025
Q2 		$3.61M Sell
138,782
-27,992
-17% -$675K ﹤0.01% 2039
2025
Q1 		$4.08M Buy
166,774
+55,058
+49% +$1.55M ﹤0.01% 2024
2024
Q4 		$3.2M Sell
111,716
-41,918
-27% -$1.43M ﹤0.01% 2185
2024
Q3 		$5.8M Buy
153,634
+91,768
+148% +$3.22M ﹤0.01% 1916
2024
Q2 		$1.95M Hold
61,866
– – ﹤0.01% 2409
2024
Q1 		$2.72M Buy
+61,866
New +$2.53M ﹤0.01% 2261

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM